[
  {
    "ts": null,
    "headline": "Abbott Laboratories: Strong Q4 Results And Bullish Outlook",
    "summary": "Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS increase.",
    "url": "https://finnhub.io/api/news?id=120a1c54cf572043ff5e09f572e1a2b4c87c977a7b0b57121746381112c324e2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737905223,
      "headline": "Abbott Laboratories: Strong Q4 Results And Bullish Outlook",
      "id": 132475044,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/75939355/image_75939355.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS increase.",
      "url": "https://finnhub.io/api/news?id=120a1c54cf572043ff5e09f572e1a2b4c87c977a7b0b57121746381112c324e2"
    }
  }
]